Elmiron Eye Disease Risk and Lawsuits
Pentosan polysulfate sodium (PPS), marketed under the brand name Elmiron, is a drug used for interstitial cystitis, a relatively rare bladder disorder. If you have taken or are taking Elmiron and have experienced eye problems, it’s important to know that researchers have documented cases of Elmiron-related eye disease in some patients with long-term exposure to the drug. In this article, we’ll discuss potential Elmiron eye disease risk and share what patients who have suffered eye damage linked to Elmiron can do to seek justice and compensation.
IMPORTANT: Doctors are urging patients who are using or have used pentosan to get screened by an ophthalmologist. Elmiron may cause eye disease and Elmiron alternatives may be available.
The risk of Elmiron-related eye disease is serious and those who have suffered eye damage due to Elmiron may be entitled to compensation. For a FREE consultation regarding a potential Elmiron eye disease claim, please call 1-800-525-7111.
There is no obligation and you won’t pay any attorney fees unless we win your case and you receive compensation.
Please call 1-800-525-7111 today to speak with an Elmiron lawyer handling these claims and lawsuits.
Elmiron Eye Disease Risk
In 2018, Dr. Neiraj Jan and his associates published a letter in the Journal of Urology, alerting readers to their findings of retinal pigmentary changes in 6 patients who were undergoing long-term therapy with Elmiron. The researchers found that patients with this condition may have injury to the retina and the underlying retinal pigment epithelium.
The case published focused on 6 female patients with interstitial cystitis who visited their doctors between May 2015 and October 2017 with pigmentary maculopathy. None of the patients had any family history of retinal disease but all had used Elmiron for long periods of time.
Maculopathy of the eye is a progressive disease which affects the center of the retina and can lead to vision loss. This disease is usually found in both eyes and affects a part of the eye in the back of the retina called the macula. The macula controls the ability to read, see detail, recognize faces and colors and focus central vision.
Potential Elmiron-caused eye disease such as pigmentary maculopathy can lead to serious and life-changing conditions such as permanent blindness.
Recent Elmiron Eye Disease Studies
In May 2019, the same team of researchers submitted a new study of ten interstitial cystitis patients who had taken pentosan and experienced macular disease. The most common symptoms were problems with reading and difficulty adapting to dim lighting. Eye examinations revealed pigmentary maculopathy.
In October 2019 the first clinical population-based Elmiron study was conducted. Researchers at Kaiser Permanente found of the 140 patients who took Elmiron for at least 5 years, 24% showed eye damage which increased when patients were exposed to higher doses of Elmiron.
The Elmiron lawsuits claim that this drug causes an eye disorder called maculopathy as well as other disorders of the retina that could lead to blindness. Anyone who took Elmiron and suffered maculopathy or other vision problems may be eligible to file a lawsuit against Elmiron.
Elmiron Eye Disease Lawsuits
Our attorneys are actively investigating these claims. If you’ve suffered eye disease such as pigmentary maculopathy, retinopathy, or scotoma after taking Elmiron, call 1-800-525-7111 for a FREE, no-obligation consultation.
There is no obligation and you won’t pay any attorney fees if we don’t recover compensation for you. There is no risk and we would love to help you if we can.
You may qualify for an Elmiron claim or lawsuit if:
- You took or have taken Elmiron for more than one year
- You’ve been diagnosed with an eye disorder or vision problem included in the list below
Qualifying injuries include:
- Pigmentary maculopathy
- Macular degeneration
- Macular/pattern dystrophy
- Retinal pigment epithelium atrophy
- Vision loss
- Vision impairment
- Scotoma (area or lost vision or blind spot)
- Halo vision
- Unilateral blindness (in one eye)
- Bilateral blindness (in both eyes)
- Blurred vision
- Distorted vision
- Reduced night vision
Please call 1-800-525-7111 today and let’s review your claim.
“It was nice to see Riddle & Brantley put me and my needs first.”
–R. Colley, Riddle & Brantley client
Our dangerous drug lawyers have been representing clients injured due to drugs like Elmiron for more than three decades and together we’ve recovered millions of dollars in compensation for victims (see disclaimer below).
Our attorneys have been recognized by such prestigious organizations and awards as:
- Multi-Million Dollar Advocates Forum
- Million Dollar Advocates Forum
- AV Preeminent by Martindale-Hubbell
- The Litigator Award
- The National Trial Lawyers Top 100
- The National Association of Distinguished Counsel
For a FREE case review concerning a potential Elmiron eye disease claim, please call 1-800-525-7111 today.
Justice Counts for those who have potentially suffered eye damage due to Elmiron and we would love to help you seek justice and compensation if we can.
Call 1-800-525-7111 today and let’s talk.
*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.
*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, The National Association of Distinguished Counsel, AV Preeminent by Martindale-Hubbell, the Litigator Award, and other memberships, awards, and accolades, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.